Afobam

Afobam may be available in the countries listed below.

Ingredient matches for Afobam

Alprazolam

Alprazolam is reported as an ingredient of Afobam in the following countries:

• Poland

International Drug Name Search

Euglucon

Euglucon may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Euglucon

Glibenclamide

Glibenclamide is reported as an ingredient of Euglucon in the following countries:

• Belgium


• Croatia (Hrvatska)


• Germany


• Italy


• Japan


• Peru


• Slovenia


• Spain


• United Kingdom

International Drug Name Search

Mixtard 50 HM

Mixtard 50 HM may be available in the countries listed below.

Ingredient matches for Mixtard 50 HM

Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Mixtard 50 HM in the following countries:

• Bangladesh

International Drug Name Search

Coretec

Coretec may be available in the countries listed below.

Ingredient matches for Coretec

Olprinone

Olprinone hydrochloride monohydrate (a derivative of Olprinone) is reported as an ingredient of Coretec in the following countries:

• Japan

International Drug Name Search

Alfaciclina

Alfaciclina may be available in the countries listed below.

Ingredient matches for Alfaciclina

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Alfaciclina in the following countries:

• Venezuela

International Drug Name Search

Dihydrocodeine, Aspirin and Caffeine

Dosage Form: capsule
Dihydrocodeine bitartrate and aspirin and caffeine

Dihydrocodeine, Aspirin and Caffeine Description

Each capsule contains 16 mg drocode (dihydrocodeine) bitartrate (Warning–may be habit-forming), 356.4 mg aspirin, and 30 mg caffeine.


The inactive ingredients present are alginic acid, cellulose, D&C Red 28, FD&C Blue 1, gelatin, iron oxides, stearic acid, and titanium dioxide.

Dihydrocodeine, Aspirin and Caffeine - Clinical Pharmacology

Dihydrocodeine is a semisynthetic narcotic analgesic, related to codeine, with multiple actions qualitatively similar to those of codeine; the most prominent of these involve the central nervous system and organs with smooth-muscle components. The principal action of therapeutic value is analgesia.

The capsule also contains the nonnarcotic antipyretic-analgesic, aspirin.

Indications and Usage for Dihydrocodeine, Aspirin and Caffeine

For the relief of moderate to moderately severe pain.

Contraindications

Hypersensitivity to dihydrocodeine, codeine, or aspirin.

Warnings

Salicylates should be used with extreme caution in the presence of peptic ulcer or coagulation abnormalities.

Drug Dependence

Dihydrocodeine can produce drug dependence of the codeine type and therefore has the potential of being abused. Psychic dependence, physical dependence, and tolerance may develop upon repeated administration of dihydrocodeine, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic-containing medications. Like other narcotic-containing medications, dihydrocodeine is subject to the provisions of the Federal Controlled Substances Act.

Usage in Ambulatory Patients

Dihydrocodeine may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks, such as driving a car or operating machinery. The patient using the dihydrocodeine bitartrate, aspirin, and caffeine capsule should be cautioned accordingly.

Interactions with other Central Nervous System Depressants

Patients receiving other narcotic analgesics, general anesthetics, tranquilizers, sedative-hypnotics, or other CNS depressants (including alcohol) concomitantly with the dihydrocodeine bitartrate, aspirin, and caffeine capsule may exhibit an additive CNS depression. When such combined therapy is contemplated, the dose of one or both agents should be reduced.

Usage in Pregnancy

Reproduction studies have not been performed in animals. There is no adequate information on whether this drug may affect fertility in human males and females or has a teratogenic potential or other adverse effect on the fetus.

Usage in Children

Preparations containing aspirin should be kept out of the reach of children. The dihydrocodeine bitartrate, aspirin, and caffeine capsule is not recommended for patients 12 years of age and under. Since there is no experience in chil­dren who have received this drug, safety and efficacy in children have not been established.

Precautions

The dihydrocodeine bitartrate, aspirin, and caffeine capsule should be given with caution to certain patients, such as the elderly or debilitated.

Drug Interactions

The CNS-depressant effects of the dihydrocodeine bitartrate, aspirin, and caffeine capsule may be additive with that of other CNS depressants. See “WARNINGS.”

Aspirin may enhance the effects of anticoagulants and inhibit the uricosuric effects of uricosuric agents.

Geriatric Use

Clinical studies of the dihydrocodeine bitartrate, aspirin, and caffeine capsule did not include sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects.

In general, dose selection for an elderly patient should be cautious, starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Adverse Reactions

The most frequently observed reactions include lightheadedness, dizziness, drowsiness, sedation, nausea, vomiting, constipation, pruritus, and skin reactions.

Dihydrocodeine, Aspirin and Caffeine Dosage and Administration

Dosage should be adjusted according to the severity of the pain and the response of the patient. The dihydrocodeine bitartrate, aspirin, and caffeine capsule is given orally. The usual adult dose is two capsules every 4 hours as need­ed for pain.

How is Dihydrocodeine, Aspirin and Caffeine Supplied

Dihydrocodeine bitartrate, aspirin, and caffeine Capsules are blue and gray, marked “CP” and “419”, supplied in:

Bottles of 100 capsules; NDC 57902-419-88

 

Store at room temperature, approx. 25°C (77°F). Keep tightly closed.

 

Dispense in tight container.

Manufactured for and distributed by:

EUSA Pharma (USA), Inc.

One Summit Square, Suite 201

1717 Langhorne Newtown Rd.

Langhorne, PA 19047
www.eusapharma.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 57902-419-88

100 Capsules

Dihydrocodeine bitartrate, aspirin, and caffeine capsules

Each capsule contains: 16 mg drocode (dihydrocodeine) bitartrate (Warning–may

be habit-forming), 356.4 mg aspirin, and 30 mg caffeine.

SEALED FOR YOUR PROTECTION

Rx Only

EUSA Pharma (USA), Inc.

DIHYDROCODEINE BITARTRATE AND ASPIRIN AND CAFFEINE  DC dihydrocodeine bitartrate and aspirin and caffeine  capsule

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 57902-419 (49708-419) Route of Administration ORAL DEA Schedule CIII

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIHYDROCODEINE BITARTRATE (DIHYDROCODEINE) DIHYDROCODEINE BITARTRATE 16 mg ASPIRIN (ASPIRIN) ASPIRIN 356.4 mg CAFFEINE (CAFFEINE) CAFFEINE 30 mg

Inactive Ingredients Ingredient Name Strength ALGINIC ACID   POWDERED CELLULOSE   D&C RED NO. 28   FD&C BLUE NO. 1   GELATIN   FERROSOFERRIC OXIDE   STEARIC ACID   TITANIUM DIOXIDE

Product Characteristics Color BLUE, GRAY Score no score Shape CAPSULE Size 19mm Flavor Imprint Code CP;419 Contains

Packaging # NDC Package Description Multilevel Packaging 1 57902-419-88 100 CAPSULE In 1 BOTTLE None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NDA	NDA011483	04/25/2011

Labeler - EUSA Pharma (USA), Inc. (038596862)

Revised: 04/2011EUSA Pharma (USA), Inc.

More Dihydrocodeine, Aspirin and Caffeine resources

• Dihydrocodeine, Aspirin and Caffeine Side Effects (in more detail)
• Dihydrocodeine, Aspirin and Caffeine Use in Pregnancy & Breastfeeding
• Dihydrocodeine, Aspirin and Caffeine Drug Interactions
• Dihydrocodeine, Aspirin and Caffeine Support Group
• 0 Reviews for Dihydrocodeine, Aspirin and Caffeine - Add your own review/rating

Compare Dihydrocodeine, Aspirin and Caffeine with other medications

• Pain

B-COL

B-COL may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for B-COL

Colistin Sulfate

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of B-COL in the following countries:

• Switzerland

International Drug Name Search

Lollarm

Lollarm may be available in the countries listed below.

Ingredient matches for Lollarm

Flavoxate

Flavoxate hydrochloride (a derivative of Flavoxate) is reported as an ingredient of Lollarm in the following countries:

• Japan

International Drug Name Search

Lorson

Lorson may be available in the countries listed below.

Ingredient matches for Lorson

Dexamethasone

Dexamethasone is reported as an ingredient of Lorson in the following countries:

• Indonesia

Dexchlorpheniramine

Dexchlorpheniramine maleate (a derivative of Dexchlorpheniramine) is reported as an ingredient of Lorson in the following countries:

• Indonesia

International Drug Name Search

Advovet suini

Advovet suini may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Advovet suini

Danofloxacin

Danofloxacin mesilate (a derivative of Danofloxacin) is reported as an ingredient of Advovet suini in the following countries:

• Italy

International Drug Name Search

Bergagyn

Bergagyn may be available in the countries listed below.

Ingredient matches for Bergagyn

Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Bergagyn in the following countries:

• Italy

International Drug Name Search

Glynase

In the US, Glynase (glyburide systemic) is a member of the drug class sulfonylureas and is used to treat Diabetes, Type 2.

US matches:

• Glynase Tablets (Micronized)


• Glynase PresTab


• Glynase Pres-Tab


• Glynase

Ingredient matches for Glynase

Glibenclamide

Glibenclamide is reported as an ingredient of Glynase in the following countries:

• Bahrain


• Oman


• United States

Glipizide

Glipizide is reported as an ingredient of Glynase in the following countries:

• India


• Myanmar


• Sri Lanka

International Drug Name Search

Ritomune

Ritomune may be available in the countries listed below.

Ingredient matches for Ritomune

Ritonavir

Ritonavir is reported as an ingredient of Ritomune in the following countries:

• Georgia


• India

International Drug Name Search

Aciclosina

Aciclosina may be available in the countries listed below.

Ingredient matches for Aciclosina

Acyclovir

Aciclovir is reported as an ingredient of Aciclosina in the following countries:

• Portugal

International Drug Name Search

Prazole

Prazole may be available in the countries listed below.

Ingredient matches for Prazole

Omeprazole

Omeprazole is reported as an ingredient of Prazole in the following countries:

• Bangladesh

International Drug Name Search

Deprizine

ranitidine hydrochloride

Dosage Form: kit for oral suspension
Deprizine

Principal Display Panel

Do not use if safety seal is broken

NDC 43093-102-01

Rx only

FusePaq™  Compounding Kit for Oral Suspension

Deprizine™

(ranitidine hydrochloride 16.8 mg/mL [15 mg/mL ranitidine], in oral suspension - compounding kit)

Description:

This kit contains active and inactive bulk materials to compound a ranitidine hydrochloride oral suspension. The instructions describe how to prepare 250 mL of a compounded oral suspension containing 16.8 mg/mL ranitidine hydrochloride (15 mg/mL as ranitidine). Other concentrations are possible. Exact strength of compounded suspension must be defined by the prescriber.

Active Ingredient:

• 4.2 g ranitidine hydrochloride, USP

Inactive Ingredients:

• 250 mL oral suspension vehicle (water, glycerin, L-glutamine, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, sodium citrate, citric acid, potassium sorbate, sodium benzoate)


• Press-in bottle adaptor for oral dispenser


• Oral dispenser


• Instructions
  

For Prescription Compounding Only

U.S. Patents Pending

CS38-A1 rev 1

Drug Label

Do not use if safety seal is broken

For Prescription Compounding Only

Ranitidine Hydrochloride

1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-N'-methyl-2-nitro-, monohydrochloride

CAS# 66357-59-3

Net contents: 4.2 g

Repackaged by:

Fusion Pharmaceuticals, LLC

Camarillo, CA 93012

CS35-A1 rev 0

Suspension Label

Do not use if safety seal is broken

For Prescription Compounding Only

Oral Suspension Vehicle

Sugar, dye, and paraben free

Ingredients: water, glycerin, L-glutamine, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, potassium sorbate, sodium benzoate

Net Contents: 250 mL (8.4 fl oz)

Manufactured for:

Fusion Pharmaceuticals LLC

Camarillo, CA 93012

CS36-A1 rev 0

Instructions Insert

NDC 43093-102-01

Rx only

FusePaq™

Deprizine™

(ranitidine hydrochloride 16.8 mg/mL [15 mg/mL ranitidine], in oral suspension - compounding kit)

FusePaq™ compounding kits provide a convenient approach to rapidly compound prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practice (cGMP).

For Prescription Compounding Only

Description:


This kit contains active and inactive bulk materials to compound a ranitidine hydrochloride oral suspension. These instructions describe how to prepare 250 mL of a compounded oral suspension containing 16.8 mg/mL ranitidine hydrochloride (15 mg/mL as ranitidine). Other concentrations are possible. Exact strength of compounded suspension must be defined by the prescriber.

Contents:

• 4.2 g ranitidine hydrochloride, USP


• 250 mL oral suspension vehicle (water, glycerin, L-glutamine, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, potassium sorbate, sodium benzoate)


• Press-in bottle adaptor for oral dispenser


• Oral dispenser


• Instructions

Instructions for Compounding

Ranitidine hydrochloride, 16.8 mg/mL (15 mg/mL as ranitidine) oral suspension

1    Remove and Inspect the Contents of the Kit


Ensure that the safety seals are present and intact on the ranitidine hydrochloride and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.

2    Prepare for Mixing


Wear gloves and eye protection during compounding operations. Remove the seal from the oral suspension bottle. Break the perforated seal and remove the cap from the ranitidine hydrochloride bottle.

3    Transfer Ranitidine Hydrochloride to the Suspension Bottle


Uncap the suspension bottle. Pour a small amount of suspension liquid (approximately one-third to one-half the volume of the ranitidine hydrochloride bottle) into the ranitidine hydrochloride bottle. Cap the ranitidine hydrochloride bottle and shake well several times to dissolve the ranitidine hydrochloride powder. Empty the contents into the suspension bottle. Cap and mix the suspension bottle. Repeat this step 3 times. Visually ensure that all of the ranitidine hydrochloride has been dissolved and transferred to the suspension bottle.

4    Complete the Mixing Process


Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times.

5    Re-label the Compounded Suspension


Label the compounded suspension per the pharmacy's standard practice. Remove or obscure the oral suspension vehicle label, since the label is no longer accurate once compounding is completed.

Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the mixed suspension between 2-8°C (36-46°F) . The compounded suspension is stable for at least eight weeks when stored under refrigeration, based upon real-time and accelerated stability studies.

Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test <61>. In addition, the suspension vehicle formulation has passed the USP <51> Antimicrobial Effectiveness Test.


An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.

U.S. Patents Pending

Manufactured by:

Fusion Pharmaceuticals LLC

768 Calle Plano

Camarillo, CA 93012

CS43-A1 rev 1

Deprizine  ranitidine hydrochloride  kit

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 43093-102

Packaging # NDC Package Description Multilevel Packaging 1 43093-102-01 1 KIT In 1 KIT None

QUANTITY OF PARTS Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE, GLASS   4.2 g Part 2 1 BOTTLE, PLASTIC   250 mL

Part 1 of 2 RANITIDINE HYDROCHLORIDE  ranitidine hydrochloride  powder, for suspension

Product Information       Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Ranitidine Hydrochloride (Ranitidine) Ranitidine Hydrochloride 4.2 g  in 4.2 g

Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 4.2 g In 1 BOTTLE, GLASS None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/08/2010

Part 2 of 2 ORAL SUSPENSION VEHICLE  suspension  liquid

Product Information       Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength No Active Ingredients Found

Inactive Ingredients Ingredient Name Strength Water   Glycerin   Glutamine   Xylitol   GLYCYRRHIZIN, AMMONIATED   Pineapple   Xanthan Gum   Stevia Leaf   Orange   Citric Acid   Sodium Citrate   Potassium Sorbate   Sodium Benzoate

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 250 mL In 1 BOTTLE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/08/2010

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		02/08/2010

Labeler - Fusion Pharmaceuticals LLC (021420944)

Establishment
Name	Address	ID/FEI	Operations
Fusion Pharmaceuticals LLC		021420944	manufacture

Revised: 02/2010Fusion Pharmaceuticals LLC

More Deprizine resources

• Deprizine Side Effects (in more detail)
• Deprizine Use in Pregnancy & Breastfeeding
• Deprizine Drug Interactions
• Deprizine Support Group
• 0 Reviews for Deprizine - Add your own review/rating

Compare Deprizine with other medications

• Duodenal Ulcer
• Duodenal Ulcer Prophylaxis
• Erosive Esophagitis
• Gastric Ulcer Maintenance Treatment
• Gastrointestinal Hemorrhage
• GERD
• Indigestion
• Pathological Hypersecretory Conditions
• Stomach Ulcer
• Stress Ulcer Prophylaxis
• Surgical Prophylaxis
• Zollinger-Ellison Syndrome

Ferridon

Ferridon may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ferridon

Iron Dextran

Iron Dextran is reported as an ingredient of Ferridon in the following countries:

• Netherlands

International Drug Name Search

Diclogrand

Diclogrand may be available in the countries listed below.

Ingredient matches for Diclogrand

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclogrand in the following countries:

• Argentina

International Drug Name Search

Dritho-Scalp Cream

Pronunciation: AN-thrah-lin
Generic Name: Anthralin
Brand Name: Examples include Dritho-Scalp and Zithronal RR

Dritho-Scalp Cream is used for:

Treating psoriasis.

Dritho-Scalp Cream is a topical antimitotic. It works by slowing the reproduction of skin cells.

Do NOT use Dritho-Scalp Cream if:

• you are allergic to any ingredient in Dritho-Scalp Cream


• you have active inflamed psoriatic eruptions

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dritho-Scalp Cream:

Some medical conditions may interact with Dritho-Scalp Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have inflamed psoriatic eruptions, folliculitis, other skin problems, or kidney disease

Some MEDICINES MAY INTERACT with Dritho-Scalp Cream. Because little, if any, of Dritho-Scalp Cream is absorbed into the blood, the risk of it interacting with another medicine is low.

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dritho-Scalp Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dritho-Scalp Cream:

Use Dritho-Scalp Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Dritho-Scalp Cream is for external use only. Avoid contact with the eyes, nose, and mouth. Do not apply to folds or creases of the skin.


• Wash and completely dry the affected area. Apply a small amount onto the lesions and rub it in gently and carefully.


• At the end of each skin treatment period, rinse the skin completely with cool to lukewarm water before washing it with soap. The margins of lesions may gradually become stained (purple/brown) as you continue to use Dritho-Scalp Cream, but the staining will disappear after your treatment is finished.


• For scalp treatment, wash your hair before applying Dritho-Scalp Cream. Rinse your hair with water, and comb it to remove scaling. Apply Dritho-Scalp Cream while your scalp is still damp. Rub the medicine into the lesions well. Do not apply Dritho-Scalp Cream to areas where there are no lesions.


• Remove any medicine that may be behind the ears.


• At the end of each scalp treatment period, rinse your hair and scalp completely with cool to lukewarm water. Shampoo your hair and scalp to remove any additional cream (which may have become red/brown).


• Wash your hands immediately after using Dritho-Scalp Cream, unless your hands are part of the treated area.


• If excessive soreness or spreading of lesions occurs after using Dritho-Scalp Cream, contact your health care provider.


• If you miss a dose of Dritho-Scalp Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Dritho-Scalp Cream.

Important safety information:

• Dritho-Scalp Cream may be harmful if swallowed. If you may have taken Dritho-Scalp Cream by mouth, contact your local poison control center or emergency room immediately.


• Dritho-Scalp Cream may stain skin or hair. Temporary discoloration of hair and fingernails may occur while using Dritho-Scalp Cream, but can be minimized by carefully applying the medicine.


• To prevent discoloration of the tub or shower, always rinse the tub or shower with lukewarm water right after washing or showering. Use a cleanser to remove any deposit on the surface of the tub or shower.


• Use protective dressings while using Dritho-Scalp Cream to prevent staining of clothing and bed sheets unless instructed otherwise by your doctor. Staining of fabric may be permanent.


• Contact with plastics and other materials may cause staining and should be avoided.


• Use Dritho-Scalp Cream with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dritho-Scalp Cream, discuss with your doctor the benefits and risks of using Dritho-Scalp Cream during pregnancy. It is unknown if Dritho-Scalp Cream is excreted in breast milk. Do not breast-feed while taking Dritho-Scalp Cream.

Possible side effects of Dritho-Scalp Cream:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Irritation; staining of treated areas.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe skin soreness; spreading of lesions.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dritho-Scalp side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Dritho-Scalp Cream:

Store Dritho-Scalp Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dritho-Scalp Cream out of the reach of children and away from pets.

General information:

• If you have any questions about Dritho-Scalp Cream, please talk with your doctor, pharmacist, or other health care provider.


• Dritho-Scalp Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dritho-Scalp Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dritho-Scalp resources

• Dritho-Scalp Side Effects (in more detail)
• Dritho-Scalp Use in Pregnancy & Breastfeeding
• Dritho-Scalp Support Group
• 0 Reviews for Dritho-Scalp - Add your own review/rating

Compare Dritho-Scalp with other medications

• Psoriasis

Lisinopril Grindeks

Lisinopril Grindeks may be available in the countries listed below.

Ingredient matches for Lisinopril Grindeks

Lisinopril

Lisinopril is reported as an ingredient of Lisinopril Grindeks in the following countries:

• Latvia


• Lithuania

International Drug Name Search

Fluvoxamina Sandoz

Fluvoxamina Sandoz may be available in the countries listed below.

Ingredient matches for Fluvoxamina Sandoz

Fluvoxamine

Fluvoxamine maleate (a derivative of Fluvoxamine) is reported as an ingredient of Fluvoxamina Sandoz in the following countries:

• Portugal


• Spain

International Drug Name Search

Cycloserine

In the US, Cycloserine (cycloserine systemic) is a member of the drug class streptomyces derivatives and is used to treat Tuberculosis - Active and Tuberculosis - Extrapulmonary.

US matches:

• Cycloserine

UK matches:

• CYCLOSERINE (King Pharmaceuticals Ltd) (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AB01

CAS registry number (Chemical Abstracts Service)

0000068-41-7

Chemical Formula

C3-H6-N2-O2

Molecular Weight

102

Therapeutic Categories

Antibacterial

Antitubercular agent

Chemical Name

3-Isoxazolidinone, 4-amino-, (R)-

Foreign Names

• Cycloserinum (Latin)
• Cycloserin (German)
• Cyclosérine (French)
• Cicloserina (Spanish)

Generic Names

• Cycloserine (OS: BAN)
• Cyclosérine (OS: DCF)
• Lilly 106-7 (IS)
• MK 65 (IS)
• PA 94 (IS)
• Ro 1-9213 (IS)
• SC 49088 (IS: Searle)
• Cicloserina (PH: F.U. IX)
• Cycloserine (PH: JP XV, USP 32, BP 1988)
• Cycloserinum (PH: Ph. Int. 2)

Brand Names

• Coxerin
  Macleods, Georgia



• Cyclorine
  Lupin, India



• Cycloserine Meji
  Meiji, Hong Kong; Meiji, Thailand



• Cycloserine
  Aspen, Australia; Biopharm, Russian Federation; King Pharmaceuticals, United Kingdom; Lilly, Israel; Lilly, Russian Federation



• Helpocerin
  Help, Romania



• Neoseryn
  AC Farma, Peru



• Seromycin
  Purdue Pharma, United States



• Siklocap
  Koçak, Turkey

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Acido nicotinico

Acido nicotinico may be available in the countries listed below.

Ingredient matches for Acido nicotinico

Nicotinic Acid

Acido nicotinico (DCIT) is also known as Nicotinic Acid (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Estrumat

Estrumat may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Estrumat

Cloprostenol

Cloprostenol is reported as an ingredient of Estrumat in the following countries:

• Norway

Cloprostenol sodium salt (a derivative of Cloprostenol) is reported as an ingredient of Estrumat in the following countries:

• Finland


• Sweden

International Drug Name Search

Liotir

Liotir may be available in the countries listed below.

Ingredient matches for Liotir

Liothyronine

Liothyronine sodium salt (a derivative of Liothyronine) is reported as an ingredient of Liotir in the following countries:

• Italy

International Drug Name Search

Niravam

In the US, Niravam (alprazolam systemic) is a member of the drug class benzodiazepines and is used to treat Anxiety, Depression, Dysautonomia, Panic Disorder and Tinnitus.

US matches:

• Niravam Orally Disintegrating Tablets


• Niravam

Ingredient matches for Niravam

Alprazolam

Alprazolam is reported as an ingredient of Niravam in the following countries:

• United States

International Drug Name Search

Botam

Botam may be available in the countries listed below.

Ingredient matches for Botam

Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Botam in the following countries:

• Italy

International Drug Name Search

Doxin

Doxin may be available in the countries listed below.

Ingredient matches for Doxin

Doxycycline

Doxycycline is reported as an ingredient of Doxin in the following countries:

• Bangladesh

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxin in the following countries:

• Philippines


• Yemen

International Drug Name Search

Amoxicillina + Acido clavulanico EG

Amoxicillina + Acido clavulanico EG may be available in the countries listed below.

Ingredient matches for Amoxicillina + Acido clavulanico EG

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina + Acido clavulanico EG in the following countries:

• Italy

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicillina + Acido clavulanico EG in the following countries:

• Italy

International Drug Name Search

P-20

P-20 may be available in the countries listed below.

Ingredient matches for P-20

Pantoprazole

Pantoprazole is reported as an ingredient of P-20 in the following countries:

• Bangladesh

International Drug Name Search

Glycerine Pfizer

Glycerine Pfizer may be available in the countries listed below.

Ingredient matches for Glycerine Pfizer

Glycerol

Glycerol is reported as an ingredient of Glycerine Pfizer in the following countries:

• Singapore

International Drug Name Search

Hydromorphon-Stada

Hydromorphon-Stada may be available in the countries listed below.

Ingredient matches for Hydromorphon-Stada

Hydromorphone

Hydromorphone hydrochloride (a derivative of Hydromorphone) is reported as an ingredient of Hydromorphon-Stada in the following countries:

• Germany

International Drug Name Search

Orudis

In the US, Orudis (ketoprofen systemic) is a member of the drug class nonsteroidal anti-inflammatory agents and is used to treat Back Pain, Fever, Frozen Shoulder, Gout - Acute, Osteoarthritis, Pain, Period Pain, Rheumatoid Arthritis and Sciatica.

US matches:

• Orudis


• Orudis KT

UK matches:

• Orudis 100 (SPC)
• Orudis 50 (SPC)
• Orudis Suppositories 100mg (SPC)

Ingredient matches for Orudis

Ketoprofen

Ketoprofen is reported as an ingredient of Orudis in the following countries:

• Australia


• Costa Rica


• Denmark


• El Salvador


• Finland


• Guatemala


• Hong Kong


• Iceland


• Italy


• Japan


• Malaysia


• Mexico


• Netherlands


• Nicaragua


• Norway


• Panama


• Philippines


• Spain


• Sweden


• United Kingdom

Ketoprofen sodium salt (a derivative of Ketoprofen) is reported as an ingredient of Orudis in the following countries:

• Mexico

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tramol-L

Tramol-L may be available in the countries listed below.

Ingredient matches for Tramol-L

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramol-L in the following countries:

• Iceland

International Drug Name Search

Halotane

Halotane may be available in the countries listed below.

Ingredient matches for Halotane

Halothane

Halothane is reported as an ingredient of Halotane in the following countries:

• Romania

International Drug Name Search

Cardular

Cardular may be available in the countries listed below.

Ingredient matches for Cardular

Doxazosin

Doxazosin is reported as an ingredient of Cardular in the following countries:

• Tunisia

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Cardular in the following countries:

• Benin


• Burkina Faso


• Cameroon


• Central African Republic


• Chad


• Congo


• Cote D'ivoire


• Gabon


• Germany


• Guinea


• Madagascar


• Mali


• Mauritania


• Mauritius


• Niger


• Senegal


• Togo


• Zaire

International Drug Name Search

Lamotaxyl

Lamotaxyl may be available in the countries listed below.

Ingredient matches for Lamotaxyl

Lamotrigine

Lamotrigine is reported as an ingredient of Lamotaxyl in the following countries:

• Peru

International Drug Name Search

Levamisol Spot On

Levamisol Spot On may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Levamisol Spot On

Levamisole

Levamisole is reported as an ingredient of Levamisol Spot On in the following countries:

• Germany


• Netherlands

International Drug Name Search

Lisinopril Almus

Lisinopril Almus may be available in the countries listed below.

Ingredient matches for Lisinopril Almus

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Almus in the following countries:

• France

International Drug Name Search

Isotrétinoïne Teva

Isotrétinoïne Teva may be available in the countries listed below.

Ingredient matches for Isotrétinoïne Teva

Isotretinoin

Isotretinoin is reported as an ingredient of Isotrétinoïne Teva in the following countries:

• France

International Drug Name Search

Apo-Amilzide

Apo-Amilzide may be available in the countries listed below.

Ingredient matches for Apo-Amilzide

Amiloride

Amiloride is reported as an ingredient of Apo-Amilzide in the following countries:

• Vietnam

Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Apo-Amilzide in the following countries:

• Canada


• Czech Republic


• Singapore

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Apo-Amilzide in the following countries:

• Canada


• Singapore


• Vietnam

International Drug Name Search

Lifen

Lifen may be available in the countries listed below.

Ingredient matches for Lifen

Fenofibrate

Fenofibrate is reported as an ingredient of Lifen in the following countries:

• Indonesia

International Drug Name Search

Azithromycin Sandoz eco

Azithromycin Sandoz eco may be available in the countries listed below.

Ingredient matches for Azithromycin Sandoz eco

Azithromycin

Azithromycin monohydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin Sandoz eco in the following countries:

• Switzerland

International Drug Name Search

L-Methionine Z

L-Methionine Z may be available in the countries listed below.

Ingredient matches for L-Methionine Z

Methionine

Methionine L- (a derivative of Methionine) is reported as an ingredient of L-Methionine Z in the following countries:

• Japan

International Drug Name Search

Dofil

Dofil may be available in the countries listed below.

Ingredient matches for Dofil

Fluconazole

Fluconazole is reported as an ingredient of Dofil in the following countries:

• Mexico

International Drug Name Search

Hanlexin

Hanlexin may be available in the countries listed below.

Ingredient matches for Hanlexin

Triazolam

Triazolam is reported as an ingredient of Hanlexin in the following countries:

• China

International Drug Name Search

Ibopamine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01CA16,S01FB03

CAS registry number (Chemical Abstracts Service)

0066195-31-1

Chemical Formula

C17-H25-N-O4

Molecular Weight

307

Therapeutic Category

Cardiac agent

Chemical Name

Propanoic acid, 2-methyl-, 4-[2-(methylamino)ethyl]-1,2-phenylene ester

Foreign Names

• Ibopaminum (Latin)
• Ibopamin (German)
• Ibopamine (French)
• Ibopamina (Spanish)

Generic Names

• Ibopamina (OS: DCIT)
• Ibopamine (OS: BAN, DCF, USAN)
• SB 7505 (IS: Simes)
• SKF 100168 (IS: SmithklineFr)

Brand Names

• Inopamil
  Zambon, Netherlands



• Scandine
  Zambon, Belgium; Zambon, Italy; Zambon, Luxembourg



• Trazyl
  Angelini, Italy

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Permit Spray

Permit Spray may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Permit Spray

Permethrin

Permethrin is reported as an ingredient of Permit Spray in the following countries:

• Switzerland

International Drug Name Search

Rissar

Rissar may be available in the countries listed below.

Ingredient matches for Rissar

Risperidone

Risperidone is reported as an ingredient of Rissar in the following countries:

• Bosnia & Herzegowina


• Bulgaria


• Serbia

International Drug Name Search

Flypel

Flypel may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Flypel

Chlorpyrifos

Chlorpyrifos is reported as an ingredient of Flypel in the following countries:

• New Zealand

Cypermethrin

Cypermethrin is reported as an ingredient of Flypel in the following countries:

• New Zealand

International Drug Name Search

Lomefloxacin

In the US, Lomefloxacin (lomefloxacin systemic) is a member of the drug class quinolones and is used to treat Bladder Infection, Bronchitis, Prostatitis, Salmonella Enteric Fever, Salmonella Gastroenteritis, Shigellosis, Transurethral Prostatectomy and Urinary Tract Infection.

US matches:

• Lomefloxacin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MA07,S01AX17

CAS registry number (Chemical Abstracts Service)

0098079-51-7

Chemical Formula

C17-H19-F2-N3-O3

Molecular Weight

351

Therapeutic Category

Antibacterial: Gyrase inhibitor

Chemical Name

3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-

Foreign Names

• Lomefloxacinum (Latin)
• Lomefloxacin (German)
• Loméfloxacine (French)
• Lomefloxacino (Spanish)

Generic Names

• Lomefloxacin (OS: BAN, USAN)
• Loméfloxacine (OS: DCF)
• NY 198 (IS: HokurikuSeiyak)
• SC 47111 (IS: Searle)
• Lomefloxacin Hydrochloride (OS: BANM, USAN, JAN)

Brand Names

• Loflox
  Meyer, Venezuela



• Lomaday
  Dr Reddys, Romania



• Lomebact
  Medivis, Italy



• Lomflox
  Ipca, Russian Federation



• Lomitas
  Intas, Myanmar



• Loransil
  Pentafarma, Portugal



• Okacin
  Novartis, Israel; Novartis, Italy; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis Ophthalmics, Vietnam; Roemmers, Peru



• Okacyn
  Adcock Ingram Pharmaceuticals, South Africa



• Optiflox
  Jayson, Bangladesh



• Bareon
  Abbott, Japan



• Chimono
  Lusofarmaco, Italy



• Décalogiflox
  Biocodex, France



• Ksenakvin
  Promed, Russian Federation



• Lamicin
  Nipa, Bangladesh



• Loflox
  Opso Saline, Bangladesh



• Logiflox
  Biocodex, France



• Lomacin
  Novartis, Mexico



• Lomaday
  Biofarma, Venezuela



• Lomax
  Julphar, Oman



• Lomebac
  Popular, Bangladesh



• Lomebact
  Shionogi, Taiwan; Shionogi Seiyaku, Japan



• Lomef
  Torrent, India



• Lomeflon
  Senju Seiyaku, Japan



• Lomeflon Minims
  Senju Seiyaku, Japan



• Lomeflox
  Aristopharma, Bangladesh; Aristopharma, Myanmar; Infaca, Dominican Republic



• Lomequin
  Incepta, Bangladesh



• Lomex
  Oftalmi, Venezuela



• Lomexel
  Medley, Myanmar



• Lomflox
  Ipca, India; Ipca, Singapore



• Lumex
  Gaco, Bangladesh



• Lyflox
  Ibn Sina, Bangladesh



• Maxaquin
  Aspen Pharmacare, South Africa; Pfizer, Brazil; Pfizer, Hong Kong; Pfizer, Mexico; Pfizer, Portugal; Pfizer, Portugal; Pfizer, Venezuela; Valeant, Italy



• Mexlo
  Square, Bangladesh



• Namicin
  Nipa, Bangladesh



• Ocacin
  Novartis, Spain



• Okacin
  Ciba Vision, Slovakia; Novartis, Argentina; Novartis, Austria; Novartis, Bangladesh; Novartis, Belgium; Novartis, Brazil; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Germany; Novartis, Estonia; Novartis, Greece; Novartis, Hong Kong; Novartis, Sri Lanka; Novartis, Luxembourg; Novartis, Latvia; Novartis, Myanmar; Novartis, Malta; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Russian Federation; Novartis, Venezuela; Novartis Ophthalmics, Colombia; Novartis Ophthalmics, Hungary; Novartis Ophthalmics, Singapore



• Ontop
  Systopic, India



• Ophtaflox
  Drug International, Bangladesh



• Senifar
  Farqui, Dominican Republic



• Uniquin
  Madaus, Italy; Medinfar, Portugal



• Utilom
  Unimed & Unihealth, Bangladesh

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Predniderm

Predniderm may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Predniderm

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Predniderm in the following countries:

• France

Prednisolone

Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Predniderm in the following countries:

• France

International Drug Name Search

Erythro-Rx

Ingredient matches for Erythro-Rx

Erythromycin

Erythromycin is reported as an ingredient of Erythro-Rx in the following countries:

• United States

International Drug Name Search

Amiloride

In the US, Amiloride (amiloride systemic) is a member of the drug class potassium-sparing diuretics and is used to treat Ascites, Edema, Heart Failure and High Blood Pressure.

US matches:

• Amiloride


• Amiloride/Hydrochlorothiazide


• Amiloride and hydrochlorothiazide


• Amiloride Hydrochloride


• Amiloride Hydrochloride/Hydrochlorothiazide

UK matches:

• Amiloride Tablets 5mg (Actavis UK Ltd)
• Amiloride Tablets 5mg (SPC)
• Amiloride Tablets BP 5mg (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C03DB01

CAS registry number (Chemical Abstracts Service)

0002609-46-3

Chemical Formula

C6-H8-Cl-N7-O

Molecular Weight

229

Therapeutic Category

Potassium-sparing diuretic agent

Chemical Name

Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-

Foreign Names

• Amiloridum (Latin)
• Amilorid (German)
• Amiloride (French)
• Amilorida (Spanish)

Generic Names

• Amiloride (OS: BAN, DCIT, DCF)
• Amipramidin (IS)
• Amipramizide (IS)
• Amiloride Hydrochloride (OS: BANM, USAN)
• Amipramidine (IS)
• MK 870 (IS)
• Amiloride (chlorhydrate d') (PH: Ph. Eur. 6)
• Amiloride Hydrochloride (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Amiloridhydrochlorid (PH: Ph. Eur. 6)
• Amiloridi hydrochloridum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Amiloride Hydrochlorothiazide (Amiloride and Hydrochlorothiazide)
  Mylan, United States; Sandoz, United States; UDL, United States; Watson, United States



• Amizide (Amiloride and Hydrochlorothiazide)
  Sanofi-Aventis, Bangladesh



• Amuretic (Amiloride and Hydrochlorothiazide)
  Dar-Al-Dawa, Tunisia



• Apo-Amilzide (Amiloride and Amiloride)
  Apotex, Vietnam



• Co-Amiloride Teva (Amiloride and Hydrochlorothiazide)
  Teva, Belgium



• Lorinid Mite (Amiloride and Hydrochlorothiazide)
  Actavis, Indonesia



• Moduretic (Amiloride and Hydrochlorothiazide)
  Lek, Slovenia



• Adco-Retic (Amiloride and Hydrochlorothiazide)
  Adcock Ingram Pharmaceuticals, South Africa



• Alverix
  Remedica, Cyprus



• Ameride
  Bristol-Myers Squibb, Spain



• Amiclaran
  Zentiva, Czech Republic; Zentiva, Slovakia



• Amicloton
  Zentiva, Slovakia



• Amilamont
  Rosemont, United Kingdom



• Amilco (Amiloride and Hydrochlorothiazide)
  OBA, Denmark



• Amiloferm (Amiloride and Hydrochlorothiazide)
  Nordic Drugs, Sweden



• Amiloferm mite (Amiloride and Hydrochlorothiazide)
  Nordic Drugs, Sweden



• Amiloretic (Amiloride and Hydrochlorothiazide)
  Aspen Pharmacare, South Africa



• Amiloretik (Amiloride and Hydrochlorothiazide)
  Hexal, Austria; Hexal, Germany; Hexal, Luxembourg



• Amilorid comp. Heumann (Amiloride and Hydrochlorothiazide)
  Heumann, Germany



• Amilorid comp. Pharmavit (Amiloride and Hydrochlorothiazid)
  Walmark, Hungary



• Amilorid comp.-ratiopharm (Amiloride and Hydrochlorothiazide)
  Ratiopharm, Germany



• Amilorid Genericon comp. (Amiloride and Hydrochlorothiazide)
  Genericon, Austria



• Amilorid HCT Helvepharm (Amiloride and Hydrochlorothiazide)
  Helvepharm, Switzerland



• Amilorid HCT Sandoz (Amiloride and Hydrochlorothiazide)
  Sandoz, Germany



• Amilorid Mylan
  Mylan, Sweden



• Amilorid/HCT AL (Amiloride and Hydrochlorothiazide)
  Aliud, Germany; Aliud, Slovakia



• Amiloride Alpharma Aps
  Alpharma, Singapore



• Amiloride Hydrochloride and Hydrochlorothiazide (Amiloride and Hydrochlorothiazide)
  Mylan, United States; Sandoz, United States; Watson, United States



• Amiloride Hydrochloride
  Mylan, United States; Par, United States; SigmaPharm Laboratories, LLC, United States



• Amiloride Hydrochlorothiazide Teva (Amiloride and Hydrochlorothiazide)
  Teva Santé, France



• Amiloride Hydrochlorothiazide (Amiloride and Hydrochlorothiazide)
  Lagap, Netherlands



• Amiloride
  Actavis, United Kingdom; Biomed, New Zealand; CP, Malta; Wockhardt, United Kingdom



• Amilostad HCT (Amiloride and Hydrochlorothiazide)
  Stada, Austria



• Amilozid-B (Amiloride and Hydrochlorothiazide)
  Teva, Hungary



• Amitrid (Amiloride and Hydrochlorothiazide)
  Leiras, Finland



• Amizide (Amiloride and Hydrochlorothiazide)
  Alphapharm, Australia; Pacific, New Zealand



• Amuretic (Amiloride and Hydrochlorothiazide)
  Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Oman



• Apo-Amiloride
  Apotex, Canada



• Apo-Amilzide
  Apotex, Czech Republic



• Apo-Amilzide (Amiloride and Hydrochlorothiazide)
  Apotex, Canada; Apotex, Singapore



• Betaretic (Amiloride and Hydrochlorothiazide)
  Be-Tabs Pharmaceuticals, South Africa



• Chlorhydrate d'Amiloride/Hydrochlorothiazide RPG (Amiloride and Hydrochlorothiazide)
  RPG, France



• Co-Amilofruse (Amiloride and Furosemide)
  CP, Malta



• Comilorid-Mepha (Amiloride and Hydrochlorothiazide)
  Mepha Pharma, Switzerland



• Diaphal (Amiloride and Furosemide)
  Pierre Fabre, Germany



• Diurex
  Orion, Finland



• Diursan (Amiloride and Hydrochlorothiazide)
  TAD, Germany



• Diuzine
  Q-Pharma, Spain



• Ecodurex (Amiloride and Hydrochlorothiazide)
  Sandoz, Switzerland



• Escoretic (Amiloride and Hydrochlorothiazide)
  Streuli Pharma, Switzerland



• Fruco (Amiloride and Furosemide)
  Teva, Ireland



• Fru-Co (Amiloride and Furosemide)
  Teva Pharmaceuticals, United Kingdom



• Frumil (Amiloride and Frusemide)
  Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Ireland; Sanofi-Aventis, New Zealand



• Frusamil (Amiloride and Furosemide)
  Sanofi-Aventis, Belgium; Sanofi-Aventis, Denmark



• Gen-Amilazide (Amiloride and Hydrochlorothiazide)
  Genpharm, Canada



• Hydro-ride (Amiloride and Hydrochlorothiazide)
  Par, United States



• Kalten (Amiloride and Hydrochlorothiazide, + Atenolol)
  Bolton, United Kingdom



• Kaltide (Amiloride and Hydrochlorothiazide)
  ACI, Bangladesh



• Kaluril
  Alphapharm, Australia; Alphapharm, Taiwan



• Logirène (Amiloride and Furosemide)
  Erempharma, France



• Loradur
  Merckle, Czech Republic



• Loradur (Amiloride and Hydrochlorothiazide)
  Ratiopharm, Austria



• Mengdaqing (Amiloride and Hydrochlorothiazide)
  Minsheng, China



• Midamor
  Cahill May Roberts, Ireland; Paddock, United States



• Milorex (Amiloride and Hydrochlorothiazide)
  Remedica, Malta



• Modamide
  Gerda, France



• Moducrin (Amiloride and Timolol, + Hydrochlorothiazide)
  Teofarma, Germany



• Moduret
  Bristol-Myers Squibb, Ireland



• Moduret (Amiloride and Hydrochlorothiazide)
  Merck Sharp & Dohme, United Kingdom



• Moduretic
  Merck, United States; Merck Sharp & Dohme, Peru



• Moduretic (Amiloride and Hydrochlorothiazide)
  Lek, Croatia (Hrvatska); Merck, United States; Merck Sharp & Dhome, Oman; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Sweden; Merck Sharp & Dohme, Slovakia; Merck Sharp & Dohme, South Africa; MSD, Switzerland; MSD, Norway; Vianex / BIANEΞ, Greece



• Modurétic (Amiloride and Hydrochlorothiazide)
  Merck Sharp & Dohme, France



• Navispare (Amiloride and Cyclopenthiazide)
  Goldshield, United Kingdom



• Normorix (Amiloride and Hydrochlorothiazide)
  Nycomed, Sweden



• Normorix mite (Amiloride and Hydrochlorothiazide)
  Nycomed, Norway; Nycomed, Sweden



• Nu-Amilzide (Amiloride and Hydrochlorothiazide)
  Nu-Pharm, Canada



• Rhefluin (Amiloride and Hydrochlorothiazide)
  Teva Pharma, Switzerland; Zentiva, Slovakia



• Sandoz Co-Amilozide (Amiloride and Hydrochlorothiazide)
  Sandoz, South Africa



• Sparkal (Amiloride and Hydrochlorothiazide)
  Hexal A/S, Denmark; Sandoz, Sweden



• Tensoflux (Amiloride and Bendroflumethiazide)
  Hennig, Germany



• Tialorid (Amiloride and Hydrochlorothiazide)
  Polpharma, Poland

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.